본문 바로가기
KERD
논문KCI 등재

Neurological Adverse Reactions to SARS-CoV-2 Vaccines

Josef Finsterer
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2023.05|Clinical Psychopharmacology and Neuroscience|제21권 제2호|pp. 222-239|DOI 10.9758/cpn.2023.21.2.222

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

COVID-19 vaccinationBrainSide effectsNeurologicalNerves.

초록

SARS-CoV-2 vaccines are not free of side effects and most commonly affect the central or peripheral nervous system (CNS, PNS). This narrative review aims to summarise recent advances in the nature, frequency, management, and outcome of neurological side effects from SARS-CoV-2 vaccines. CNS disorders triggered by SARS-CoV-2 vaccines include headache, cerebro-vascular disorders (venous sinus thrombosis [VST], ischemic stroke, intracerebral hemorrhage, subarachnoid bleeding, reversible, cerebral vasoconstriction syndrome, vasculitis, pituitary apoplexy, Susac syndrome), inflammatory diseases (encephalitis, meningitis, demyelinating disorders, transverse myelitis), epilepsy, and a number of other rarely reported CNS conditions. PNS disorders related to SARS-CoV-2 vaccines include neuropathy of cranial nerves, mono-/polyradiculitis (Guillain–Barre syndrome [GBS]), Parsonage–Turner syndrome (plexitis), small fiber neuropathy, myasthenia, myositis/dermatomyositis, rhabdomyolysis, and a number of other conditions. The most common neurological side effects are facial palsy, intracerebral hemorrhage, VST, and GBS. The underlying pathophysiology is poorly understood, but several speculations have been generated to explain the development of CNS/PNS disease after SARS-CoV-2 vaccination. In conclusion, neurological side effects develop with any type of SARS-CoV-2 vaccine and are diverse, can be serious and even fatal, and should be taken seriously to initiate early treatment and improve outcome and avoid fatalities.

Abstract

SARS-CoV-2 vaccines are not free of side effects and most commonly affect the central or peripheral nervous system (CNS, PNS). This narrative review aims to summarise recent advances in the nature, frequency, management, and outcome of neurological side effects from SARS-CoV-2 vaccines. CNS disorders triggered by SARS-CoV-2 vaccines include headache, cerebro-vascular disorders (venous sinus thrombosis [VST], ischemic stroke, intracerebral hemorrhage, subarachnoid bleeding, reversible, cerebral vasoconstriction syndrome, vasculitis, pituitary apoplexy, Susac syndrome), inflammatory diseases (encephalitis, meningitis, demyelinating disorders, transverse myelitis), epilepsy, and a number of other rarely reported CNS conditions. PNS disorders related to SARS-CoV-2 vaccines include neuropathy of cranial nerves, mono-/polyradiculitis (Guillain–Barre syndrome [GBS]), Parsonage–Turner syndrome (plexitis), small fiber neuropathy, myasthenia, myositis/dermatomyositis, rhabdomyolysis, and a number of other conditions. The most common neurological side effects are facial palsy, intracerebral hemorrhage, VST, and GBS. The underlying pathophysiology is poorly understood, but several speculations have been generated to explain the development of CNS/PNS disease after SARS-CoV-2 vaccination. In conclusion, neurological side effects develop with any type of SARS-CoV-2 vaccine and are diverse, can be serious and even fatal, and should be taken seriously to initiate early treatment and improve outcome and avoid fatalities.

참고문헌 (129)

  1. Finsterer J, "Neurological side effects of SARS-CoV-2 vaccinations", Acta Neurol Scand, 145, pp.5~9 (2022)
  2. Castillo RA, "Neurological manifestations associated with COVID-19 vaccine", Neurologia (2022)[DOI]
  3. Kaulen LD, "Neurological autoimmune diseases following vaccinations against SARS-CoV-2 : a case series", Eur J Neurol, 29, pp.555~563 (2022)
  4. Doubrovinskaia S, "Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) : a follow-up study", Eur J Neurol, 30, pp.463~473 (2023)
  5. Undugodage C, "Reactogenicity to ChAdOx1nCoV-19 vaccine in health care workers : a multicenter observational study in Sri Lanka", Ceylon Med J, 66, pp.177~184 (2021)
  6. Ceccardi G, "Post COVID-19 vaccination headache:a clinical and epidemiological evaluation", Front Pain Res(Lausanne), 3, pp.994140~ (2022)
  7. Oonk NGM, "SARS-CoV-2 vaccine-related neurological complications", Neurol Sci, 43, pp.2295~2297 (2022)
  8. Aliberti L, "Pituitary apoplexy and COVID-19 vaccination:a case report and literature review", Front Endocrinol(Lausanne), 13, pp.1035482~ (2022)
  9. Suwanwela NC, "Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination : an extended case series", J Headache Pain, 23, pp.13~ (2022)
  10. Mehta PR, "Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination-a report of two UK cases", Brain Behav Immun, 95, pp.514~517 (2021)
  11. Kanack AJ, "Vaccine-induced immune thrombotic thrombocytopenia", Best Pract Res Clin Haematol, 35, pp.101381~ (2022)
  12. van de Munckhof A, "Outcomes of cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after the acute phase", Stroke, 53, pp.3206~3210 (2022)
  13. Rahmig J, "Acute ischemic stroke in the context of SARS-CoV-2 vaccination : a systematic review", Neuropsychiatr Dis Treat, 18, pp.1907~1916 (2022)
  14. Stefanou MI, "Acute arterial ischemic stroke following COVID-19 vaccination : a systematic review and meta-analysis", Neurology, 99, pp.e1465~e1474 (2022)
  15. López-Mena D, "Stroke among SARS-CoV-2 vaccine recipients in Mexico : a nationwide descriptive study", Neurology, 98, pp.e1933~e1941 (2022)
  16. Finsterer J, "First reported case of reversible cerebral vasoconstriction syndrome after a SARS-CoV-2 vaccine", Cureus, 13, pp.e19987~ (2021)
  17. Blauenfeldt RA, "Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine", J Thromb Haemost, 19, pp.1771~1775 (2021)
  18. Luisa V, "Ischemic stroke shortly after vaccination against SARS-CoV-2 : a case-control study", J Neurol Sci, 436, pp.120209~ (2022)
  19. Yoshida K, "Repeated cardioembolic stroke after COVID-19 mRNA vaccination : a case report", J Stroke Cerebrovasc Dis, 31, pp.106233~ (2022)
  20. Dutta S, "Analysis of neurological adverse events reported in VigiBase from COVID-19 vaccines", Cureus, 14, pp.e21376~ (2022)
  21. de Mélo Silva ML Jr, "Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination : a case report", Acta Neurol Scand, 144, pp.717~718 (2021)
  22. Gómez-Roldós A, "Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine", Rev Neurol, 75, pp.199~202 (2022)
  23. Lin YH, "Moyamoya disease with Sjogren disease and autoimmune thyroiditis presenting with left intracranial hemorrhage after messenger RNA-1273 vaccination:a case report", Medicine(Baltimore), 101, pp.e28756~ (2022)
  24. Takeyama R, "Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report", Acta Neurochir(Wien), 164, pp.543~547 (2022)
  25. Finsterer J, "Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine", Brain Hemorrhages, 3, pp.26~28 (2022)
  26. Wilting FNH, "Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine : clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia", Cureus, 13, pp.e17637~ (2021)
  27. Purkayastha P, "Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis", BMJ Case Rep, 14, pp.e245092~ (2021)
  28. Wolthers SA, "Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19", Ugeskr Laeger, 183, pp.V05210425~ (2021)
  29. Choi Jae-Ki, "Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea", Journal of Korean Medical Science, 36(31), pp.1~6 (2021), 대한의학회[DOI]
  30. Finsterer J, "Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine", Brain Hemorrhages, 2, pp.165~167 (2021)
  31. Waraich A, "Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 vaccination", BMJ Case Rep, 14, pp.e245440~ (2021)
  32. Scully M, "Pathologic antibodies to platelet factor 4 after ChAdOx1nCoV-19 vaccination", N Engl J Med, 384, pp.2202~2211 (2021)
  33. D’Agostino V, "A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration", J Pers Med, 11, pp.285~ (2021)
  34. Wolf ME, "Thrombocytopenia and intracranial venous sinus thrombosis after"COVID-19 vaccine AstraZeneca"exposure", J Clin Med, 10, pp.1599~ (2021)
  35. Bjørnstad-Tuveng TH, "Fatal cerebral haemorrhage after COVID-19 vaccine", Tidsskr Nor Laegeforen, 141 (2021)
  36. Gambichler T, "Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccination", Br J Dermatol, 186, pp.e83~ (2022)
  37. Arias M, "Polymyalgia rheumatica and giant cell arteritis with intracranial involvement postvaccination anti-COVID-19", Med Clin(Engl Ed), 159, pp.e43~e44 (2022)
  38. Callejas Rubio JL, "Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis", Med Clin(Barc), 158, pp.91~92 (2022)
  39. Maleki A, "COVID-19recombinant mRNA vaccines and serious ocular inflammatory side effects : real or coincidence?", J Ophthalmic Vis Res, 16, pp.490~501 (2021)
  40. Nakatani K, "Systemic vasculitis following SARS-CoV-2 mRNA vaccination demonstrated on FDG PET", CT, 2022, pp.47, e403~e405
  41. Roncati L, "Apropos of menstrual changes and abnormal uterine bleeding after COVID-19 vaccination", Brain Hemorrhages (2022)[DOI]
  42. Ach T, "The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions", Therapie (2022)[DOI]
  43. Zainordin NA, "Pituitary apoplexy after COVID-19 vaccination : a case report", J Clin Transl Endocrinol Case Rep, 25, pp.100123~ (2022)
  44. Lund AM, "COVID-19 vaccination might induce reversible cerebral vasoconstriction syndrome attacks:a case report", Vaccines(Basel), 10, pp.823~ (2022)
  45. Malerbi FK, "Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen", BMJ Case Rep, 15, pp.e247159~ (2022)
  46. Werner J, "New-onset refractory status epilepticus due to autoimmune encephalitis after vaccination against SARS-CoV-2 : first case report", Front Neurol, 13, pp.946644~ (2022)
  47. Shyu S, "Clinical manifestation, management, and outcomes in patients with COVID-19 vaccine-induced acute encephalitis:two case reports and a literature review", Vaccines(Basel), 10, pp.1230~ (2022)
  48. Maramattom BV, "Central nervous system adverse events after ChAdOx1 vaccination", Neurol Sci, 43, pp.3503~3507 (2022)
  49. Vences MA, "Post-vaccinal encephalitis with early relapse after BNT162b2 (COMIRNATY) COVID-19 vaccine:a case report", Vaccines(Basel), 10, pp.1065~ (2022)
  50. Gao JJ, "Acute encephalitis after COVID-19 vaccination : a case report and literature review", Hum Vaccin Immunother, 18, pp.2082206~ (2022)
  51. Asaduzzaman M, "COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone : a case report", J Neuroimmunol, 368, pp.577883~ (2022)
  52. Dinoto A, "Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders", Mult Scler Relat Disord, 63, pp.103827~ (2022)
  53. George M, "Neurological disorders seen during second wave of SARSCoV-2 pandemic from two tertiary care centers in central and Southern Kerala", Ann Indian Acad Neurol, 24, pp.917~926 (2021)
  54. Zlotnik Y, "Case report : anti-LGI1 encephalitis following COVID-19 vaccination", Front Immunol, 12, pp.813487~ (2022)
  55. Flannery P, "Acute psychosis due to anti-N-methyl D-aspartate receptor encephalitis following COVID-19 vaccination : a case report", Front Neurol, 12, pp.764197~ (2021)
  56. Albsheer K, "Post-COVID-19 vaccine limbic encephalitis : a case report", Cureus, 14, pp.e29003~ (2022)
  57. Walter A, "A neurologist’s rhombencephalitis after comirnaty vaccination. A change of perspective", Neurol Res Pract, 3, pp.56~ (2021)
  58. Pongpitakmetha T, "COVID-19 related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement", BMC Infect Dis, 22, pp.640~ (2022)
  59. Bensaidane MR, "Case report : acute necrotizing encephalopathy following COVID-19 vaccine", Front Neurol, 13, pp.872734~ (2022)
  60. Siriratnam P, "Acute haemorrhagic necrotizing encephalopathy in the setting of SARS-CoV-2 vaccination : a case report and literature review", Acta Neurol Belg, 123, pp.303~305 (2023)
  61. Rinaldi V, "CNS inflammatory demyelinating events after COVID-19 vaccines : a case series and systematic review", Front Neurol, 13, pp.1018785~ (2022)
  62. Francis AG, "Acute inflammatory diseases of the central nervous system after SARS-CoV-2 vaccination", Neurol Neuroimmunol Neuroinflamm, 10, pp.e200063~ (2022)
  63. Mousa H, "Acute disseminated encephalomyelitis(ADEM)after consecutive exposures to mycoplasma and COVID vaccine : a case report", Cureus, 14, pp.e26258~ (2022)
  64. Ahmad HR, "Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination", Am J Case Rep, 23, pp.e936574~ (2022)
  65. Poli K, "Multiple autoimmune syndromes including acute disseminated encephalomyelitis, myasthenia gravis, and thyroiditis following messenger ribonucleic acid-based COVID-19 vaccination : a case report", Front Neurol, 13, pp.913515~ (2022)
  66. Yazdanpanah F, "Acute disseminated encephalomyelitis(ADEM)after SARS-CoV-2 vaccination : a case report", Radiol Case Rep, 17, pp.1789~1793 (2022)
  67. Lazaro LG, "Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2 : a case report", Brain Behav Immun Health, 20, pp.100439~ (2022)
  68. Nagaratnam SA, "Acute disseminated encephalomyelitis with bilateral optic neuritis following ChAdOx1 COVID-19 vaccination", BMC Neurol, 22, pp.54~ (2022)
  69. Shimizu M, "An 88-year-old woman with acute disseminated encephalomyelitis following messenger ribonucleic acid-based COVID-19 vaccination", eNeurologicalSci, 25, pp.100381~ (2021)
  70. Mumoli L, "ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination", Neurol Sci, 43, pp.763~766 (2022)
  71. Rinaldi V, "ADEM after ChAdOx1 nCoV-19 vaccine : a case report", Mult Scler, 28, pp.1151~1154 (2022)
  72. Kania K, "Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2", Ann Clin Transl Neurol, 8, pp.2000~2003 (2021)
  73. Vogrig A, "Acute disseminated encephalomyelitis after SARSCoV-2 vaccination", Clin Neurol Neurosurg, 208, pp.106839~ (2021)
  74. Kits A, "Fatal acute hemorrhagic encephalomyelitis and antiphospholipid antibodies following SARS-CoV-2vaccination: a case report", Vaccines(Basel), 10, pp.2046~ (2022)
  75. Ancau M, "Case series : acute hemorrhagic encephalomyelitis after SARS-CoV-2 vaccination", Front Neurol, 12, pp.820049~ (2022)
  76. Mörz M, "A case report: multifocal necrotizing encephalitis and myocarditis after BNT162b2 mRNA vaccination against COVID-19", Vaccines (Basel), 10, pp.1651~ (2022)
  77. Brecl Jakob G, "Acute cerebellitis requiring posterior fossa decompression after COVID-19 vaccination in an ocrelizumab-treated patient with multiple sclerosis", Neurol Sci, 43, pp.3509~3511 (2022)
  78. Chan AC, "Aseptic meningitis after BNT-162b2 COVID-19 vaccination", Brain Behav Immun Health, 19, pp.100406~ (2022)
  79. Saito K, "Aseptic meningitis after vaccination of the BNT162b2mRNA COVID-19 vaccine", Neurol Sci, 42, pp.4433~4435 (2021)
  80. Wiley ZC, "Uveomeningeal syndrome presenting with bilateral optic disc edema and multiple evanescent white dots syndrome(MEWDS)", Am J Ophthalmol Case Rep, 26, pp.101538~ (2022)
  81. Ebrahimi N, "CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines : a case series", Vaccine, 41, pp.1003~1008 (2023)
  82. Pignolo A, "Clinical onset and multiple sclerosis relapse after SARS-CoV-2 infection", Neurol Int, 13, pp.695~700 (2021)
  83. Jarius S, "MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2(SARS-CoV-2) : case report and comprehensive review of the literature", J Neurol, 269, pp.5198~5212 (2022)
  84. Anamnart C, "Newly diagnosed neuromyelitis optica spectrum disorders following vaccination : case report and systematic review", Mult Scler Relat Disord, 58, pp.103414~ (2022)
  85. Badrawi N, "Post COVID-19 vaccination neuromyelitis optica spectrum disorder : case report &MRI findings", Radiol Case Rep, 16, pp.3864~3867 (2021)
  86. Hernandez-Vega M, "Optic neuromyelitis after vaccination against SARS-CoV-2", BMJ Case Rep, 15, pp.e252309~ (2022)
  87. Garg RK, "Tumefactive demyelinating brain lesion developing after administration of adenovector-based COVID-19 vaccine : a case report", Neurol India, 70, pp.409~411 (2022)
  88. LaRovere KL, "Changes in distribution of severe neurologic involvement in US pediatric inpatients with COVID-19 or multisystem inflammatory syndrome in children in 2021 vs 2020", JAMA Neurol, 80, pp.91~98 (2023)
  89. Shetty AJ, "Longitudinally extensive transverse myelitis following ChAdOx1 nCoV-19vaccine", J Postgrad Med, 68, pp.179~181 (2022)
  90. Tan WY, "Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine : a case report", BMC Neurol, 21, pp.395~ (2021)
  91. Notghi AA, "Lessons of the month 1: longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination", Clin Med(Lond), 21, pp.e535~e538 (2021)
  92. Pagenkopf C, "A case of longitudinally extensive transverse myelitis following vaccination against COVID-19", J Neuroimmunol, 358, pp.577606~ (2021)
  93. Matheny M, "Severe exacerbations of systemic capillary leak syndrome after COVID-19 vaccination : a case series", Ann Intern Med, 174, pp.1476~1478 (2021)
  94. Mahamid A, "Pfizer", BioNTech SARSCoV-2 vaccine as a potential trigger for the development of narcolepsy : a case report, 2022, pp.18, 2503~2506
  95. Frange C, "COVID-19 and central nervous system hypersomnias", Curr Sleep Med Rep, 8, pp.42~49 (2022)
  96. Daouk SK, "Zoster meningitis in an immunocompetent child after COVID-19 vaccination, California, USA", Emerg Infect Dis, 28, pp.1523~1524 (2022)
  97. Shrestha Y, "The prevalence of inverse health consequences of COVID-19 vaccines : a post-vaccination study", Vacunas, 23, pp.S67~S76 (2022)
  98. Kaya A, "A case of trigeminal neuralgia developing after a COVID-19 vaccination", J Neurovirol, 28, pp.181~182 (2022)
  99. Onoda K, "Trigeminal neuropathy after tozinameran vaccination against COVID-19 in postmicrovascular decompression for trigeminal neuralgia : illustrative case", J Neurosurg Case Lessons, 3, pp.CASE22101~ (2022)
  100. Lee S, "Central nervous system demyelination following COVID-19 mRNA-based vaccination : two case reports and literature review", J Cent Nerv Syst Dis, 14, pp.11795735221102747~ (2022)
  101. Finsterer J, "Guillain-Barre syndrome related to SARS-CoV-2 vaccinations", Clinics(Sao Paulo), 77, pp.100113~ (2022)
  102. Kim JE, "Associations of Guillain-Barré syndrome with coronavirus disease 2019vaccination : disproportionality analysis using the World Health Organization pharmacovigilance database", J Peripher Nerv Syst, 27, pp.206~214 (2022)
  103. Rashmi Devaraj, "Spectrum of Neurological Complications Following COVID-19 Vaccination in India", Journal of Clinical Neurology, 18(6), pp.681~691 (2022), 대한신경과학회
  104. Lakkireddy M, "Parsonage-Turner Syndrome following Covishield(AstraZeneca ChAdOx1 nCoV-19)vaccination : a case report", Cureus, 14, pp.e27867~ (2022)
  105. Waheed W, "Post COVID-19vaccine small fiber neuropathy", Muscle Nerve, 64, pp.E1~E2 (2021)
  106. Chan AR, "A case series of dermatomyositis following SARS-CoV-2 vaccination", Front Med(Lausanne), 9, pp.1013378~ (2022)
  107. Buj M, "Systemic capillary leak syndrome after SARS-CoV-2 infection and after COVID-19 vaccination: a scoping review in relation to a clinical case", Rev Clin Esp(Barc), 222, pp.374~376 (2022)
  108. Chaudhari PJ, "Facial palsy induced by Covaxin in adolescent female-a rare case report", Curr Drug Saf (2022)[DOI]
  109. Malhotra HS, "COVID-19 vaccination-associated myelitis", QJM, 114, pp.591~593 (2021)
  110. Gogu AE, "Tolosa-Hunt Syndrome and hemorrhagic encephalitis presenting in a patient after COVID-19 vaccination followed by COVID-19 infection", Brain Sci, 12, pp.902~ (2022)
  111. Ohara H, "Cytotoxic lesions of the corpus callosum after COVID-19 vaccination", Neuroradiology, 64, pp.2085~2089 (2022)
  112. Mohseni Afshar Z, "A review of the potential neurological adverse events of COVID-19 vaccines", Acta Neurol Belg, 123, pp.9~44 (2023)
  113. Murvelashvili N, "A case of hypophysitis following immunization with the mRNA-1273 SARS-CoV-2vaccine", J Investig Med High Impact Case Rep, 9, pp.23247096211043386~ (2021)
  114. Ankireddypalli AR, "A case of hypophysitis associated with SARS-CoV-2vaccination", AACE Clin Case Rep, 8, pp.204~209 (2022)
  115. Sriuoginys S, "De novo presentation of idiopathic intracranial hypertension(IIH)associated with COVID-19 infection", Neurohospitalist, 12, pp.691~692 (2022)
  116. Morita S, "Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine : a case report", BMC Endocr Disord, 22, pp.185~ (2022)
  117. Althaus K, "Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia", Haematologica, 106, pp.2170~2179 (2021)
  118. Rodríguez-Martín M, "Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine", Enferm Infecc Microbiol Clin(Engl Ed), 40, pp.47~48 (2022)
  119. Basnet K, "Isolated abducens nerve palsy following AstraZeneca vaccine: a case report", Ann Med Surg(Lond), 81, pp.104434~ (2022)
  120. Cicalese MP, "Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination : change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response", BMJ Case Rep, 15, pp.e246485~ (2022)
  121. Lee H, "Multiple cranial nerve palsies with small angle exotropia following COVID-19 mRNA vaccination in an adolescent : a case report", World J Clin Cases, 10, pp.12289~12294 (2022)
  122. Finsterer J, "Small fiber neuropathy as a complication of SARS-CoV-2 vaccinations", J Family Med Prim Care, 11, pp.4071~4073 (2022)
  123. Roncati L, "Cubital tunnel syndrome temporally after COVID-19 vaccination", Trop Med Infect Dis, 7, pp.62~ (2022)
  124. Ramdas S, "SARS-CoV-2 vaccination and new-onset myasthenia gravis : a report of 7 cases and review of the literature", Neuromuscul Disord, 32, pp.785~789 (2022)
  125. Watad A, "Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA", DNA SARS-CoV-2 vaccination, 2021, pp.9, 435~
  126. Rayamajhi S, "Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine : a comparative study among healthcare professionals of Nepal", PLoS One, 17, pp.e0272729~ (2022)
  127. Pucchio A, "Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager", Pediatr Nephrol (2022)[DOI]
  128. Park KA, "Ocular motility disorders following coronavirus disease-19vaccination", Graefes Arch Clin Exp Ophthalmol (2022)[DOI]
  129. Eren F, "Multifocal motor neuropathy after SARS-CoV-2 vaccination : a causal or coincidental association?", J Int Med Res, 50, pp.3000605221110709~ (2022)

관련 논문AI추천

Spectrum of Neurological Complications Following COVID-19 Vaccination in IndiaAmar Naidu, Chinmay Nagesh, Parthasarathy Satishchandra, Peerzada Shafi, Rashmi Devaraj대한신경과학회 · Journal of Clinical Neurology2022 · 제18권 제6호Guillain-Barré Syndrome Following the ChAdOx1-S/nCoV-19 Vaccine: A Case Report오성일, 이석윤대한근전도전기진단의학회 · 대한근전도 전기진단의학회지2022 · 제24권 제1호Aseptic Meningitis Following Second Dose of an mRNA Coronavirus Disease 2019 Vaccine in a Healthy Male: Case Report and Literature Review김영리, 허상택, Kang Han Sol, Kim Ju Eun, Kim Misun, Oh Hyunjoo, Yoo Jeong Rae대한감염학회 · Infection and Chemotherapy2022 · 제54권 제1호Reports of Guillain–Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS DatabaseAnna Bashmakov, Charles Andrews, Danuel Snelgrove, Julio A. Chalela, Niren Kapoor대한신경과학회 · Journal of Clinical Neurology2023 · 제19권 제2호Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case ReportLilie Lalisang, Pamela Tiffani, Pricilla Yani Gunawan대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제4호Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination김백균, 김아련, 신혜림, 이순태대한신경과학회 · Journal of Clinical Neurology2022 · 제18권 제1호

이 간행물의 다른 논문 (19건)

Sublingual Dexmedetomidine for the Treatment of Agitation in Patients with Schizophrenia and Bipolar DisorderColin M. Smith, Andrew Muzyk, Morgan Santalucia, Hannah Bunnpp. 215-221Effects of Vitamin D Supplementation on Children with Autism Spectrum Disorder: A Systematic Review and Meta-analysisZhaoXu Lu, Jian Yang, Min Zhang, MeiYan Song, XiaoLan Huang, LaLa Mi, Xiaodai Cui, YiRan Wupp. 240-251A Primer on Interoception and its Importance in PsychiatryVanteemar S. Sreeraj, Ganesan Venkatasubramanian, Swarna Buddha Nayok, Venkataram Shivakumarpp. 252-261Prediction of the Duration to Next Admission for an Acute Affective Episode in Patients with Bipolar I DisorderYung-Han Chang, Pao-Huan Chen, Chun-Ming Shih, Chi-Kang Chang, Chia-Pei Lin, Hsin-Chien Lee, El-Wui Lohpp. 262-270Effect of Home-based Self-administered Transcranial Direct Stimulation in Patients with Mild to Moderate Major Depressive Disorder: A Single-arm, Multicentral Trial채정호, Young-Hoon Ko, Woojae Myung, Tae Hyon Ha, Sekye Jeon, Jihoon Oh, Seung-Hwan Lee, Hwa-Young Lee, 김도훈pp. 271-278
원문 보기